{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T04:15:37Z","timestamp":1791000937463,"version":"4.1.0"},"reference-count":83,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,12,21]],"date-time":"2018-12-21T00:00:00Z","timestamp":1545350400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"DOI":"10.3389\/fonc.2018.00650","type":"journal-article","created":{"date-parts":[[2018,12,20]],"date-time":"2018-12-20T23:59:46Z","timestamp":1545350386000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":43,"title":["MicroRNAs for the Diagnosis and Management of Malignant Pleural Mesothelioma: A Literature Review"],"prefix":"10.3389","volume":"8","author":[{"given":"Giuseppe","family":"Lo Russo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Tessari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Capece","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Galli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"de Braud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina Chiara","family":"Garassino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario","family":"Palmieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,12,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"491","DOI":"10.3978\/j.issn.2225-319X.2012.11.04","article-title":"Malignant pleural mesothelioma: an epidemiological perspective","volume":"1","author":"Robinson","year":"2012","journal-title":"Ann Cardiothorac Surg."},{"key":"B2","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1183\/09059180.00007014","article-title":"Malignant pleural mesothelioma: history, controversy and future of a manmade epidemic","volume":"24","author":"Roe","year":"2015","journal-title":"Eur Respir Rev."},{"key":"B3","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1080\/01913120252959227","article-title":"Malignant mesothelioma and occupational exposure to asbestos: a clinicopathological correlation of 1445 cases","volume":"26","author":"Roggli","year":"2002","journal-title":"Ultrastruct Pathol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1080\/08958370600835377","article-title":"The role of SV40 in malignant mesothelioma and other human malignancies","volume":"18","author":"Pershouse","year":"2006","journal-title":"Inhal Toxicol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1007\/s12199-007-0017-6","article-title":"Pathology of mesothelioma","volume":"13","author":"Inai","year":"2008","journal-title":"Environ Health Prev Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jss.2015.01.043","article-title":"Impact of mesothelioma histologic subtype on outcomes in the surveillance, epidemiology, and end results database","volume":"196","author":"Meyerhoff","year":"2015","journal-title":"J Surg Res."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1056\/NEJMra050152","article-title":"Advances in malignant mesothelioma","volume":"353","author":"Robinson","year":"2005","journal-title":"N Engl J Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.rmed.2017.02.013","article-title":"State-of-the-art: radiological investigation of pleural disease","volume":"124","author":"Hallifax","year":"2017","journal-title":"Respir Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1002\/cncy.21342","article-title":"The diagnosis of malignant mesothelioma in effusion cytology: A reappraisal and results of a multi-institution survey","volume":"121","author":"Paintal","year":"2013","journal-title":"Cancer Cytopathol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"978","DOI":"10.5858\/arpa.2013-0381-RA","article-title":"Malignant mesothelioma diagnosis","volume":"139","author":"Arif","year":"2015","journal-title":"Arch Pathol Lab Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1007\/s10147-011-0369-1","article-title":"Pathological and molecular biological approaches to early mesothelioma","volume":"17","author":"Tsujimura","year":"2012","journal-title":"Int J Clin Oncol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1043\/1543-2165-133.8.1317","article-title":"Guidelines for pathologic diagnosis of malignant mesothelioma: a consensus statement from the international mesothelioma interest group","volume":"133","author":"Husain","year":"2009","journal-title":"Arch Pathol Lab Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"18","DOI":"10.5301\/tj.5000436","article-title":"Systemic approach to malignant pleural mesothelioma: what news of chemotherapy, targeted agents and immunotherapy?","volume":"102","author":"Signorelli","year":"2016","journal-title":"Tumori"},{"key":"B14","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1165\/rcmb.2013-0472TR","article-title":"Immunotherapy for malignant pleural mesothelioma. current status and future prospects","volume":"50","author":"Wong","year":"2014","journal-title":"Am J Respir Cell Mol Biol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"78193","DOI":"10.18632\/oncotarget.20409","article-title":"Targeting microRNA to improve diagnostic and therapeutic approaches for malignant mesothelioma","volume":"8","author":"Birnie","year":"2017","journal-title":"Oncotarget"},{"key":"B16","doi-asserted-by":"publisher","first-page":"E595","DOI":"10.3390\/ijms19020595","article-title":"Secreted and tissue miRNAs as diagnosis biomarkers of malignant pleural mesothelioma","volume":"19","author":"Mart\u00ednez-Rivera","year":"2018","journal-title":"Int J Mol Sci."},{"key":"B17","doi-asserted-by":"publisher","first-page":"S342","DOI":"10.21037\/jtd.2017.10.88","article-title":"Molecular markers and new diagnostic methods to differentiate malignant from benign mesothelial pleural proliferations: a literature review","volume":"10","author":"Bruno","year":"2018","journal-title":"J Thorac Dis."},{"key":"B18","doi-asserted-by":"publisher","first-page":"58606","DOI":"10.18632\/oncotarget9686","article-title":"Diagnostic value of microRNAs in asbestos exposure and malignant mesothelioma: systematic review and qualitative meta-analysis","volume":"7","author":"Micolucci","year":"2016","journal-title":"Oncotarget"},{"key":"B19","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1002\/gcc.20669","article-title":"CDKN2A, NF2, and JUN are dysregulated among other genes by miRNAs in malignant mesothelioma\u2014A miRNA microarray analysis","volume":"48","author":"Guled","year":"2009","journal-title":"Genes Chromosomes Cancer"},{"key":"B20","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1097\/JTO.0b013e31820db125","article-title":"MicroRNAs dysregulation in human malignant pleural mesothelioma","volume":"6","author":"Balatti","year":"2011","journal-title":"J Thorac Oncol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.yexmp.2014.09.016","article-title":"Analysis of microRNA expression signatures in malignant pleural mesothelioma, pleural inflammation, and atypical mesothelial hyperplasia reveals common predictive tumorigenesis-related targets","volume":"97","author":"Ram\u00edrez-Salazar","year":"2014","journal-title":"Exp Mol Pathol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"635748","DOI":"10.1155\/2015\/635748","article-title":"microRNA and mRNA features of malignant pleural mesothelioma and benign asbestos-related pleural effusion","volume":"2015","author":"Ak","year":"2015","journal-title":"Biomed Res Int."},{"key":"B23","doi-asserted-by":"publisher","first-page":"18713","DOI":"10.18632\/oncotarget.7666","article-title":"microRNAs are differentially regulated between MDM2-positive and negative malignant pleural mesothelioma","volume":"7","author":"Walter","year":"2016","journal-title":"Oncotarget"},{"key":"B24","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1007\/s00428-017-2133-z","article-title":"miRNA regulation is important for DNA damage repair and recognition in malignant pleural mesothelioma","volume":"470","author":"Mairinger","year":"2017","journal-title":"Virchows Arch."},{"key":"B25","doi-asserted-by":"publisher","first-page":"42847","DOI":"10.18632\/oncotarget.17086","article-title":"A subset of microRNAs defining the side population of a human malignant mesothelioma cell line","volume":"8","author":"Kim","year":"2017","journal-title":"Oncotarget"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1378\/chest12-2770","article-title":"miR-1 induces growth arrest and apoptosis in malignant mesothelioma","volume":"144","author":"Xu","year":"2013","journal-title":"Chest"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.3892\/ijo20163358","article-title":"Differential microRNA expression profiling of mesothelioma and expression analysis of miR-1 and miR-214 in mesothelioma","volume":"48","author":"Amatya","year":"2016","journal-title":"Int J Oncol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1038\/cgt.2011.50","article-title":"EphrinA1 inhibits malignant mesothelioma tumor growth via let-7 microRNA-mediated repression of the RAS oncogene","volume":"18","author":"Khodayari","year":"2011","journal-title":"Cancer Gene Ther."},{"key":"B29","doi-asserted-by":"publisher","first-page":"4481","DOI":"10.2147\/IJNS41782","article-title":"Targeted delivery of let-7a microRNA encapsulated ephrin-A1 conjugated liposomal nanoparticles inhibit tumor growth in lung cancer","volume":"8","author":"Lee","year":"2013","journal-title":"Int J Nanomed."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.7150\/ijbs13453","article-title":"Blockage of epithelial to mesenchymal transition and upregulation of let 7b are critically involved in ursolic acid induced apoptosis in malignant mesothelioma cell","volume":"12","author":"Sohn","year":"2016","journal-title":"Int J Biol Sci."},{"key":"B31","doi-asserted-by":"publisher","first-page":"3128","DOI":"10.1093\/annonc\/mdt412","article-title":"Restoring expression of miR-16: a novel approach to therapy for malignant pleural mesothelioma","volume":"24","author":"Reid","year":"2013","journal-title":"Ann Oncol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1016\/j.jtho.2017.05.024","article-title":"Tumour suppressor microRNAs contribute to the regulation of PD-L1 expression in malignant pleural mesothelioma","volume":"12","author":"Kao","year":"2017","journal-title":"J Thorac Oncol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1002\/1878-0261.12150","article-title":"A link between the fibroblast growth factor axis and the miR-16 family reveals potential new treatment combinations in mesothelioma","volume":"12","author":"Schelch","year":"2018","journal-title":"Mol Oncol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s12943-016-0529-z","article-title":"KCa1.1, a calcium-activated potassium channel subunit alpha 1, is targeted by miR-17-5p and modulates cell migration in malignant pleural mesothelioma","volume":"15","author":"Cheng","year":"2016","journal-title":"Mol Cancer"},{"key":"B35","doi-asserted-by":"publisher","first-page":"e0170999","DOI":"10.1371\/journalpone0170999","article-title":"Identification of MiR- 21-5p as a functional regulator of mesothelin expression using MicroRNA capture affinity coupled with next generation sequencing","volume":"12","author":"De","year":"2017","journal-title":"PLoS ONE"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1158\/0008-5472.CAN-09-3993","article-title":"hsa-miR-29c* is linked to the prognosis of malignant pleural mesothelioma","volume":"70","author":"Pass","year":"2009","journal-title":"Cancer Res."},{"key":"B37","doi-asserted-by":"publisher","first-page":"22809","DOI":"10.1074\/jbc.M110.100354","article-title":"Pro-tumorigenic effects of miR-31 loss in mesothelioma","volume":"285","author":"Ivanov","year":"2010","journal-title":"J Biol Chem."},{"key":"B38","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1159\/000334237","article-title":"miR-34a expression, cell cycle arrest and cell death of malignant mesothelioma cells upon treatment with radiation, docetaxel or combination treatment","volume":"81","author":"Ghawanmeh","year":"2011","journal-title":"Oncology"},{"key":"B39","doi-asserted-by":"publisher","first-page":"4965","DOI":"10.1158\/1078-0432.ccr-10-3040","article-title":"Epigenetic silencing of MicroRNA-34b\/c plays an important role in the pathogenesis of malignant pleural mesothelioma","volume":"17","author":"Kubo","year":"2011","journal-title":"Clin Canc Res."},{"key":"B40","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.3892\/or20132351","article-title":"Downregulation of microRNA-34 induces cell proliferation and invasion of human mesothelial cells","volume":"29","author":"Tanaka","year":"2013","journal-title":"Oncol Rep."},{"key":"B41","first-page":"4871","article-title":"MicroRNA miR-34b\/c enhances cellular radiosensitivity of malignant pleural mesothelioma cells","volume":"32","author":"Maki","year":"2012","journal-title":"Anticancer Res."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1158\/0008-5472.CAN-13-2062","article-title":"Tumor suppressor alterations cooperate to drive aggressive mesotheliomas with enriched cancer stem cells via a p53-miR-34a-c-Met axis","volume":"74","author":"Menges","year":"2014","journal-title":"Cancer Res."},{"key":"B43","doi-asserted-by":"publisher","first-page":"23","DOI":"10.18926\/AMO\/52140","article-title":"Preclinical evaluation of microRNA-34b\/c delivery for malignant pleural mesothelioma","volume":"68","author":"Ueno","year":"2014","journal-title":"Acta Med Okayama"},{"key":"B44","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1089\/ars20135215","article-title":"MicroRNA-126 suppresses mesothelioma malignancy by targeting IRS1 and interfering with the mitochondrial function","volume":"21","author":"Tomasetti","year":"2014","journal-title":"Antioxid Redox Signal."},{"key":"B45","doi-asserted-by":"publisher","first-page":"36338","DOI":"10.18632\/oncotarget8916","article-title":"MicroRNA-126 induces autophagy by altering cell metabolism in malignant mesothelioma","volume":"7","author":"Tomasetti","year":"2016","journal-title":"Oncotarget"},{"key":"B46","first-page":"6223","article-title":"Methylation-associated silencing of microRNA-126 and its host gene EGFL7 in malignant pleural mesothelioma","volume":"35","author":"Andersen","year":"2015","journal-title":"Anticancer Res."},{"key":"B47","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.jtho.2017.10.016","article-title":"Dysregulated expression of the MicroRNA miR-137 and Its target YBX1 contribute to the invasive characteristics of malignant pleural mesothelioma","volume":"13","author":"Johnson","year":"2018","journal-title":"J Thorac Oncol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"5319","DOI":"10.1038\/onc2013476","article-title":"Protumorigenic effects of mir-145 loss in malignant pleural mesothelioma","volume":"33","author":"Cioce","year":"2014","journal-title":"Oncogene"},{"key":"B49","doi-asserted-by":"publisher","first-page":"23480","DOI":"10.18632\/oncotarget.4346","article-title":"miR-193a- 3p is a potential tumor suppressor in malignant pleural mesothelioma","volume":"6","author":"Williams","year":"2015","journal-title":"Oncotarget"},{"key":"B50","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/modpathol2011144","article-title":"Epithelial-mesenchymal transition in malignant mesothelioma","volume":"25","author":"Fassina","year":"2012","journal-title":"Mod Pathol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1158\/1541-7786MCR-14-0442","article-title":"Loss of miR-223 and JNK signaling contribute to elevated stathmin in malignant pleural mesothelioma","volume":"13","author":"Birnie","year":"2015","journal-title":"Mol Cancer Res."},{"key":"B52","first-page":"1996","article-title":"MicroRNA-302b targets Mcl-1 and inhibits cell proliferation and induces apoptosis in malignant pleural mesothelioma cells","volume":"6","author":"Khodayari","year":"2016","journal-title":"Am J Cancer Res."},{"key":"B53","doi-asserted-by":"publisher","first-page":"2365","DOI":"10.3892\/or.2014.3481","article-title":"MiR-379\/411 cluster regulates IL-18 and contributes to drug resistance in malignant pleural mesothelioma","volume":"32","author":"Yamamoto","year":"2014","journal-title":"Oncol Rep."},{"key":"B54","doi-asserted-by":"publisher","first-page":"3140","DOI":"10.1038\/s41598-017-02694-0","article-title":"Deregulation of miRNAs in malignant pleural mesothelioma is associated with prognosis and suggests an alteration of cell metabolism","volume":"7","author":"De","year":"2017","journal-title":"Sci Rep."},{"key":"B55","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s12032-014-0303-2","article-title":"Upregulation of microRNA-31 associates with a poor prognosis of malignant pleural mesothelioma with sarcomatoid component","volume":"31","author":"Matsumoto","year":"2014","journal-title":"Med Oncol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1165\/rcmb.2009-0060OC","article-title":"microRNA signature of malignant meosthlelioma with potential diagnostic and prognostic implications","volume":"42","author":"Busacca","year":"2010","journal-title":"Am J Respir Cell Mol Biol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"771","DOI":"10.2353\/jmoldx.2010.090169","article-title":"A diagnostic assay based on microRNA expression accurately identifies malignant pleural mesothelioma","volume":"12","author":"Benjamin","year":"2010","journal-title":"J Mol Diagn."},{"key":"B58","doi-asserted-by":"publisher","first-page":"2859","DOI":"10.1002\/ijc.25285","article-title":"Downregulated microRNAs in the differential diagnosis of malignant pleural mesothelioma","volume":"127","author":"Gee","year":"2010","journal-title":"Int J Cancer"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmoldx.2014.03.002","article-title":"Diagnostic potentialof mir-126, mir-143, mir-145, and mir-652 in malignant pleural mesothelioma","volume":"16","author":"Andersen","year":"2014","journal-title":"J Mol Diagn"},{"key":"B60","doi-asserted-by":"publisher","first-page":"e18232","DOI":"10.1371\/journal.pone.0018232","article-title":"Association of MiR-126 with soluble mesothelin-related peptides, a marker for malignant mesothelioma","volume":"6","author":"Santarelli","year":"2011","journal-title":"PLoS ONE"},{"key":"B61","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1002\/cncy21646","article-title":"Young investigator challenge: MicroRNA-21\/MicroRNA-126 profiling as a novel tool for the diagnosis of malignant mesothelioma in pleural effusion cytology","volume":"124","author":"Cappellesso","year":"2016","journal-title":"Cancer Cytopathol."},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1002\/cncy.21869","article-title":"Mir-130a as a diagnostic marker to differentiate malignant mesothelioma from lung adenocarcinoma in pleural effusion cytology","volume":"125","author":"Cappellesso","year":"2017","journal-title":"Cancer Cytopathol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.lungcan.2015.09.021","article-title":"Combined circulating epigenetic markers to improve mesothelin performance in the diagnosis of malignant mesothelioma","volume":"90","author":"Santarelli","year":"2015","journal-title":"Lung Cancer"},{"key":"B64","doi-asserted-by":"publisher","first-page":"740","DOI":"10.17877\/DE290R-6925","article-title":"Identification of circulating miRNA profiles that distinguish malignant pleural mesothelioma from lung adenocarcinoma","volume":"13","author":"Gayosso-G\u00f3mez","year":"2014","journal-title":"EXCLI J."},{"key":"B65","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1097\/JTO.0b013e3182572e83","article-title":"Increased circulating miR-625-3p: a potential biomarker for patients with malignant pleural mesothelioma","volume":"7","author":"Kirschner","year":"2012","journal-title":"J Thorac Oncol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"82700","DOI":"10.18632\/oncotarget.12408","article-title":"Circulating microRNAs found dysregulated in ex-exposed asbestos workers and pleural mesothelioma patients as potential new biomarkers","volume":"7","author":"Bononi","year":"2016","journal-title":"Oncotarget"},{"key":"B67","doi-asserted-by":"publisher","first-page":"9280170","DOI":"10.1155\/2017\/9280170","article-title":"Circulating miR-132-3p as a candidate diagnostic biomarker for malignant mesothelioma","volume":"2017","author":"Weber","year":"2017","journal-title":"Dis Markers"},{"key":"B68","doi-asserted-by":"publisher","first-page":"129","DOI":"10.2217\/bmm-2017-0224","article-title":"Clinical evaluation of circulating miR-548a-3p and\u221220a expression in malignant pleural mesothelioma patients","volume":"12","author":"Matboli","year":"2018","journal-title":"Biomark Med."},{"key":"B69","doi-asserted-by":"publisher","first-page":"e0176680","DOI":"10.1371\/journal.pone.0176680","article-title":"Plasmatic extracellular vesicle microRNAs in malignant pleural mesothelioma and asbestos-exposed subjects suggest a 2-miRNA signature as potential biomarker of disease","volume":"12","author":"Cavalleri","year":"2017","journal-title":"PLoS ONE"},{"key":"B70","doi-asserted-by":"publisher","first-page":"e30221","DOI":"10.1371\/journal.pone.0030221","article-title":"Identification of miRNA-103 in the Cellular fraction of human peripheral blood as a potential biomarker for malignant mesothelioma \u201cA Pilot Study\u201d","volume":"7","author":"Weber","year":"2012","journal-title":"PLoS ONE"},{"key":"B71","doi-asserted-by":"publisher","first-page":"e114483","DOI":"10.1371\/journal.pone.0114483","article-title":"Combination ofmir-103a-3p and mesothelin improves the biomarker performance of malignant mesothelioma diagnosis","volume":"9","author":"Weber","year":"2014","journal-title":"PLoS ONE"},{"key":"B72","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.lungcan.2013.09.017","article-title":"The degree of microRNA-34b\/c methylation in serum-circulating DNA is associated with malignant pleural mesothelioma","volume":"82","author":"Muraoka","year":"2013","journal-title":"Lung Cancer"},{"key":"B73","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/jmolonc201411007","article-title":"MiR-score: a novel 6-microRNA signature that predicts survival outcomes in patients with malignant pleural mesothelioma","volume":"9","author":"Kirschner","year":"2015","journal-title":"Mol Oncol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"68627","DOI":"10.18632\/oncotarget.19800","article-title":"Downregulation of miR-99a\/let-7c\/miR-125b miRNA cluster predicts clinical outcome in patients with unresected malignant pleural mesothelioma","volume":"8","author":"Truini","year":"2017","journal-title":"Oncotarget"},{"key":"B75","doi-asserted-by":"publisher","first-page":"9645940","DOI":"10.1155\/2017\/9645940","article-title":"MicroRNA expression in malignant pleural mesothelioma and asbestosis: a pilot study","volume":"2017","author":"Mozzoni","year":"2017","journal-title":"Dis Markers"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinbiochem.2012.02.009","article-title":"Clinical significance of circulating mir-126 quantification in malignant mesothelioma patients","volume":"45","author":"Tomasetti","year":"2012","journal-title":"Clin Biochem."},{"key":"B77","doi-asserted-by":"publisher","first-page":"e0135331","DOI":"10.1371\/journal.pone.0135331","article-title":"Two different serum miRNA signatures correlate with the clinical outcome and histological subtype in pleural malignant mesothelioma patients","volume":"10","author":"Lamberti","year":"2015","journal-title":"PLoS ONE"},{"key":"B78","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.jtho.2016.11.358","article-title":"Refiniment of the prognostic miR-score for use in diagnostic specimens from chemo-na\u00efve malignant pleural mesothelioma patients","volume":"12","author":"Kirschner","year":"2017","journal-title":"J Thorac Oncol."},{"key":"B79","unstructured":"Evaluation of a combined mricrorna-clinical score as prognostic factor for malignant pleural mesothelioma\n            KirschnerM\n            VrugtB\n            FriessM\n            MeerangM\n            WildP\n            VanZandwijk N\n          YokohamaIASLC 18 Th World Conference on Lung Cancer; 2017 October 15\u2013182017"},{"key":"B80","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1016\/S1470-2045(17)30621-6","article-title":"Safety and activity of microRNA-loaded minicells in patients with recurrent malignant pleural mesothelioma: a first-in-man, phase 1, open-label, dose-escalation study","volume":"18","author":"van","year":"2017","journal-title":"Lancet Oncol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1016\/j.biopha.2017.07.075","article-title":"Regulation of microRNA using promising dietary phytochemicals: possible preventive and treatment option of malignant mesothelioma","volume":"94","author":"Sayeed","year":"2017","journal-title":"Biomed Pharmacother."},{"key":"B82","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1164\/rccm.201503-0461LE","article-title":"A Significant metabolic and radiological response after a novel targeted MicroRNA-based treatment approach in malignant pleural mesothelioma","volume":"191","author":"Kao","year":"2015","journal-title":"Am J Respir Crit Care Med."},{"key":"B83","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.2217\/epi-2016-0035","article-title":"Clinical development of TargomiRs, a miRNA mimic-based treatment for patients with recurrent thoracic cancer","volume":"8","author":"Reid","year":"2016","journal-title":"Epigenomics"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2018.00650\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,12,21]],"date-time":"2018-12-21T00:00:10Z","timestamp":1545350410000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2018.00650\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,21]]},"references-count":83,"alternative-id":["10.3389\/fonc.2018.00650"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2018.00650","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,21]]},"article-number":"650"}}